Beta-adrenergic axis and heart disease

Trends Genet. 2001 Oct;17(10):S44-9. doi: 10.1016/s0168-9525(01)02487-8.

Abstract

Beta-adrenergic receptors (beta-ARs) belong to a large family of G-protein-coupled receptors (GPCRs) that form the interface between the sympathetic nervous system and the cardiovascular system. The beta-AR signal system is one of the most powerful regulators of cardiac function, mediated by the effects of the sympathetic transmitters epinephrine and norepinephrine. In a number of cardiac diseases, however, the biology of beta-AR signaling pathways is altered dramatically. Here we discuss the role of beta-AR signaling in the normal and abnormal heart and how the use of genetically engineered mouse models has helped in our understanding of the pathophysiology of cardiac disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiomegaly / genetics
  • Cardiomyopathies / genetics
  • Cyclic AMP-Dependent Protein Kinases / genetics
  • Cyclic AMP-Dependent Protein Kinases / physiology
  • Disease Models, Animal
  • Heart Diseases / etiology
  • Heart Diseases / genetics*
  • Heart Diseases / physiopathology
  • Heart Failure / genetics
  • Humans
  • Mice
  • Mice, Knockout
  • Models, Cardiovascular
  • Phosphatidylinositol 3-Kinases / genetics
  • Receptors, Adrenergic, beta / genetics
  • Receptors, Adrenergic, beta / physiology*
  • Signal Transduction
  • beta-Adrenergic Receptor Kinases

Substances

  • Receptors, Adrenergic, beta
  • Phosphatidylinositol 3-Kinases
  • Cyclic AMP-Dependent Protein Kinases
  • beta-Adrenergic Receptor Kinases